Business
QT Imaging Announces Collaboration with Olea Medical to Advance Visualization and Quantitative Analytics for Its Cloud Imaging Platform
NOVATO, Calif.--(BUSINESS WIRE)-- QT Imaging Holdings, Inc. (OTCQB: QTIH) (“QT Imaging” or the “Company”), a medical device company dedicated to transforming

About this update from Qt Imaging Holdings, Inc.
[{"type":"text","content":" NOVATO, Calif.--(BUSINESS WIRE)--\nQT Imaging Holdings, Inc. (OTCQB: QTIH) (“QT Imaging” or the “Company”), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, today announced a collaboration with Olea Medical, a renowned provider of advanced medical imaging software, recognized for its clinically validated quantitative analytics and multimodality expertise across magnetic resonance (MR), computed tomography (CT) and ultrasound (US) imaging.\n\n\n \nThis collaboration enhances QT Imaging’s Cloud SaaS Platform by integrating Olea Medical’s advanced visualization, quantitative analytics and AI-ready imaging technologies to support clinical interpretation, research workflows, and quantitative imaging analysis. The Olea collaboration builds on QT Imaging’s existing cloud infrastructure, to be delivered through InteleShare platform, which provides the enterprise PACS and cloud backbone for QT Imaging’s clinical and research deployments.\n\n\n \nTogether, these capabilities strengthen QT Imaging’s end-to-end imaging ecosystem, enabling secure cloud-based delivery of QT Imaging Breast Acoustic CT™ studies with high-performance visualization, advanced quantitative analysis, and multimodality integration.\n\n\n \nUnder the collaboration:\n\n\n \n\nQT imaging data will be enabled for relevant clinical interpretation within QT Imaging’s infrastructure, incorporating Olea Medical’s validated visualization and analytics technologies.\n\n\n\nThe combined solution supports a scalable multimodality breast imaging approach, integrating mammography, digital breast tomosynthesis (DBT), ultrasound, MR imaging and QT Imaging studies across the breast care pathway.\n\n\n\nAdvanced quantitative analytics, segmentation and volumetric analysis, will support improved lesion characterization, diagnostic confidence, and clinical efficiency.\n\n\n\nSecure, network-enabled access enables multi-institutional collaboration, centralized research workflows, and standardized clinical trial support.\n\n\n\n \nThe collaboration aligns with QT Imaging’s roadmap to expand adoption of its Breast Acoustic CT™ technology while supporting future AI- and machine learning-driven analytics, delivered through its cloud infrastructure.\n\n\n \nAs part of the collaboration, QT Imaging will distribu...